NCT03598998 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- Adverse Events were assessed through 8 treatment cycles (21 days per cycle) up to 90 days from last dose (approximately 9 months). All-Cause Mortality was monitored/assessed up to 43 months from the start time of the initial treatment.
- Other-event reporting threshold
- 0%
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Phase I - Dose Level 1: Pembrolizumab 200mg + Pralatrexate 20mg/m2 | 2 / 7 | 7 / 7 | 5 / 7 |
| Phase I - Dose Level 2: Pembrolizumab 200mg + Pralatrexate 30mg/m2 | 3 / 6 | 6 / 6 | 5 / 6 |
Serious adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- CLOSTRIDIOIDES DIFFICILE
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 6
- num Events
- 2
- term
- DISEASE PROGRESSION
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- FEVER
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- TUMOR FLARE
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- ENCEPHALITIS INFECTION
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- HERPES SIMPLEX REACTIVATION
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Injury, poisoning and procedural complications
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- VASCULAR ACCESS COMPLICATION
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- LARYNGEAL OBSTRUCTION
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- RESPIRATORY FAILURE
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 5
- num At Risk
- 7
- num Events
- 10
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- ANEMIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 7
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- EOSINOPHILIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- PLATELET COUNT INCREASED
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 7
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- SINUS BRADYCARDIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 7
- num Events
- 10
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 6
- num Events
- 2
- term
- SINUS TACHYCARDIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- VENTRICULAR ARRHYTHMIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- CATARACT
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- PERIORBITAL EDEMA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 7
- num Events
- 3
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- CONSTIPATION
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 7
- num Events
- 3
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 6
- num Events
- 3
- term
- DIARRHEA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- DRY MOUTH
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 7
- num Events
- 2
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- DYSPHAGIA
Complete source fields
- event Groups
- deaths Num Affected
- 5
- deaths Num At Risk
- 7
- description
- Patients receive pralatrexate 20mg/m2 IV over 3-5 minutes on days 1 and 8 and pembrolizumab 200mg IV over 30 minutes on day 1. Courses repeat every 21 days for up to 24 months in the absence of disease progression or unacceptable toxicity.
- id
- EG000
- other Num Affected
- 7
- other Num At Risk
- 7
- serious Num Affected
- 2
- serious Num At Risk
- 7
- title
- Phase I - Dose Level 1: Pembrolizumab 200mg + Pralatrexate 20mg/m2
- deaths Num Affected
- 5
- deaths Num At Risk
- 6
- description
- Patients receive pralatrexate 30mg/m2 IV over 3-5 minutes on days 1 and 8 and pembrolizumab 200mg IV over 30 minutes on day 1. Courses repeat every 21 days for up to 24 months in the absence of disease progression or unacceptable toxicity.
- id
- EG001
- other Num Affected
- 6
- other Num At Risk
- 6
- serious Num Affected
- 3
- serious Num At Risk
- 6
- title
- Phase I - Dose Level 2: Pembrolizumab 200mg + Pralatrexate 30mg/m2
- frequency Threshold
- 0
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 5
- num At Risk
- 7
- num Events
- 10
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- ANEMIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 7
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- EOSINOPHILIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- PLATELET COUNT INCREASED
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 7
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- SINUS BRADYCARDIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 7
- num Events
- 10
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 6
- num Events
- 2
- term
- SINUS TACHYCARDIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- VENTRICULAR ARRHYTHMIA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- CATARACT
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- PERIORBITAL EDEMA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 7
- num Events
- 3
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- CONSTIPATION
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 7
- num Events
- 3
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 6
- num Events
- 3
- term
- DIARRHEA
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- DRY MOUTH
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 7
- num Events
- 2
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- DYSPHAGIA
- serious Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- CLOSTRIDIOIDES DIFFICILE
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 6
- num Events
- 2
- term
- DISEASE PROGRESSION
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- FEVER
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- TUMOR FLARE
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- ENCEPHALITIS INFECTION
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- HERPES SIMPLEX REACTIVATION
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Injury, poisoning and procedural complications
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- VASCULAR ACCESS COMPLICATION
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- LARYNGEAL OBSTRUCTION
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- CTCAE (5.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- RESPIRATORY FAILURE
- time Frame
- Adverse Events were assessed through 8 treatment cycles (21 days per cycle) up to 90 days from last dose (approximately 9 months). All-Cause Mortality was monitored/assessed up to 43 months from the start time of the initial treatment.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle